CONSTRUÇÃO DE ASSINATURA MOLECULAR ASSOCIADA AO ESTADO DE “STEMNESS” EM LEUCEMIA MIELOIDE AGUDA

Autor: Aguiar, AMG, Coelho-Silva, JL, Silva, VJ, Reis-Silva, MT, Martins, DAP, França-Neto, PL, Santos, LP, Bezerra, MAC, Lucena-Araujo, AR

Publikováno v: In Hematology, Transfusion and Cell Therapy October 2024 46 Supplement 4:S405-S406

ANÁLISE DA EXPRESSÃO DOS GENES LARS1, LARS2, IARS1 E IARS2 ASSOCIADA AO DESFECHO CLÍNICO DE PACIENTES COM LEUCEMIA MIELOIDE AGUDA

Autor: Santos, IC, Reis-Silva, MT, Silva, VJ, França-Neto, PL, Coelho-Silva, JL, Lucena-Araújo, AR, Bessoni, MT, Aguiar, AMG, Santos, LP, Alcântara, BV

Publikováno v: In Hematology, Transfusion and Cell Therapy October 2024 46 Supplement 4:S396-S397

Clinical significance of mitochondrial DNA content in acute promyelocytic leukaemia.

Autor: Pereira-Martins DA; Department of Genetics, Federal University of Pernambuco, Recife, Brazil.; Department of Hematology, Cancer Research Centre Groningen, University Medical Centre Groningen, University of Groningen, Groningen, the Netherlands.; Department of Medical Imaging, Haematology, and Oncology, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto, SP, Brazil.; Center for Cell Based Therapy, São Paulo Research Foundation, Ribeirão Preto, SP, Brazil., Coelho-Silva JL; Department of Genetics, Federal University of Pernambuco, Recife, Brazil.; Department of Medical Imaging, Haematology, and Oncology, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto, SP, Brazil.; Center for Cell Based Therapy, São Paulo Research Foundation, Ribeirão Preto, SP, Brazil., Weinhäuser I; Department of Hematology, Cancer Research Centre Groningen, University Medical Centre Groningen, University of Groningen, Groningen, the Netherlands.; Department of Medical Imaging, Haematology, and Oncology, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto, SP, Brazil.; Center for Cell Based Therapy, São Paulo Research Foundation, Ribeirão Preto, SP, Brazil., Franca-Neto PL; Department of Genetics, Federal University of Pernambuco, Recife, Brazil., Silveira DR; Myeloid Leukaemia Genomics and Biology Group, School of Cancer and Pharmaceutical Sciences, King's College London, London, UK., Ortiz C; Department of Medical Imaging, Haematology, and Oncology, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto, SP, Brazil.; Center for Cell Based Therapy, São Paulo Research Foundation, Ribeirão Preto, SP, Brazil., Moreira-Aguiar A; Department of Genetics, Federal University of Pernambuco, Recife, Brazil., Lima MM; Department of Genetics, Federal University of Pernambuco, Recife, Brazil., Koury LC; Department of Medical Imaging, Haematology, and Oncology, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto, SP, Brazil.; Center for Cell Based Therapy, São Paulo Research Foundation, Ribeirão Preto, SP, Brazil., de Melo RA; Department of Internal Medicine, University of Pernambuco, Recife, Brazil., Glória AB; Hematology Division, Federal University of Minas Gerais, Belo Horizonte, Brazil., Fagundes EM; Hematology Division, Federal University of Minas Gerais, Belo Horizonte, Brazil., Lino BK; Hematology and Hemotherapy Center, University of Campinas, Campinas, Brazil., Pagnano K; Hematology and Hemotherapy Center, University of Campinas, Campinas, Brazil., Bittencourt R; Hematology Division, Federal University of Paraná, Curitiba, Brazil., Nunes E; Hematology Division, Federal University of Rio Grande do Sul, Porto Alegre, Brazil., Traina F; Department of Medical Imaging, Haematology, and Oncology, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto, SP, Brazil.; Center for Cell Based Therapy, São Paulo Research Foundation, Ribeirão Preto, SP, Brazil., Figueiredo-Pontes L; Department of Medical Imaging, Haematology, and Oncology, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto, SP, Brazil.; Center for Cell Based Therapy, São Paulo Research Foundation, Ribeirão Preto, SP, Brazil., Keating A; Princess Margaret Cancer Centre, Toronto, Ontario, Canada., Tallman MS; Leukemia Service, Memorial Sloan-Kettering Cancer Center/Weill Cornell Medical College, New York City, New York, USA., Ribeiro RC; Department of Oncology, St. Jude Children's Research Hospital, Memphis, Tennessee, USA., Dilon R; Department of Medical and Molecular Genetics, King's College London School of Medicine, London, UK., Ganser A; Department of Hematology, Hemostasis, Oncology, and Stem Cell Transplantation, Hannover Medical School, Hannover, Germany., Sanz MA; Department of Hematology, Valencia University Medical School, Valencia, Spain.; CIBERONC, Instituto Carlos III, Madrid, Spain., Berliner N; Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA., Valk P; Department of Hematology, Erasmus University Medical Center, Rotterdam, The Netherlands., Löwenberg B; Department of Hematology, Erasmus University Medical Center, Rotterdam, The Netherlands., Ottone T; Department of Biomedicine and Prevention, University of Tor Vergata, Rome, Italy.; Santa Lucia Foundation, I.R.C.C.S., Neuro-Oncohematology, Rome, Italy., Noguera NI; Department of Biomedicine and Prevention, University of Tor Vergata, Rome, Italy.; Santa Lucia Foundation, I.R.C.C.S., Neuro-Oncohematology, Rome, Italy., Voso MT; Department of Biomedicine and Prevention, University of Tor Vergata, Rome, Italy.; Santa Lucia Foundation, I.R.C.C.S., Neuro-Oncohematology, Rome, Italy., Paoloni F; Santa Lucia Foundation, I.R.C.C.S., Neuro-Oncohematology, Rome, Italy., Fazi P; Gruppo Italiano Malattie Ematologiche Maligne dell'Adulto (GIMEMA), GIMEMA Foundation, Rome, Italy., Ammatuna E; Department of Hematology, Cancer Research Centre Groningen, University Medical Centre Groningen, University of Groningen, Groningen, the Netherlands., Huls G; Department of Hematology, Cancer Research Centre Groningen, University Medical Centre Groningen, University of Groningen, Groningen, the Netherlands., Schuringa JJ; Department of Hematology, Cancer Research Centre Groningen, University Medical Centre Groningen, University of Groningen, Groningen, the Netherlands., Rego EM; Department of Medical Imaging, Haematology, and Oncology, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto, SP, Brazil.; Center for Cell Based Therapy, São Paulo Research Foundation, Ribeirão Preto, SP, Brazil.; Hematology Division, LIM31, Faculdade de Medicina, University of São Paulo, São Paulo, Brazil., Lucena-Araujo AR; Department of Genetics, Federal University of Pernambuco, Recife, Brazil.

Publikováno v: British journal of haematology [Br J Haematol] 2023 Jan; Vol. 200 (2), pp. 170-174. Date of Electronic Publication: 2022 Oct 20.

Co-occurrence of DNMT3A, NPM1, FLT3 mutations identifies a subset of acute myeloid leukemia with adverse prognosis.

Autor: Bezerra MF; Keizo Asami Immunopathology Laboratory, Federal University of Pernambuco, Recife, Brazil.; Aggeu Magalhães Institute, Oswaldo Cruz Foundation, Recife, Brazil., Lima AS; Department of Genetics, Federal University of Pernambuco, Recife, Brazil., Piqué-Borràs MR; Department of Biomedicine, University of Basel, Basel, Switzerland., Silveira DR; Hematology Division, LIM31, Faculdade de Medicina, University of São Paulo, São Paulo, Brazil.; Hematology Department, AC Camargo Cancer Center, São Paulo, Brazil., Coelho-Silva JL; Department of Genetics, Federal University of Pernambuco, Recife, Brazil.; Department of Internal Medicine, Medical School of Ribeirão Preto, Ribeirão Preto, Brazil., Pereira-Martins DA; Department of Genetics, Federal University of Pernambuco, Recife, Brazil.; Department of Internal Medicine, Medical School of Ribeirão Preto, Ribeirão Preto, Brazil., Weinhäuser I; Department of Internal Medicine, Medical School of Ribeirão Preto, Ribeirão Preto, Brazil., Franca-Neto PL; Department of Genetics, Federal University of Pernambuco, Recife, Brazil., Quek L; Department of Hematology, Oxford University Hospitals National Health Service (NHS) Foundation Trust, Oxford, United Kingdom.; Medical Research Council (MRC) Molecular Hematology Unit, Weatherall Institute of Molecular Medicine (WIMM), University of Oxford, Oxford, United Kingdom., Corby A; Medical Research Council (MRC) Molecular Hematology Unit, Weatherall Institute of Molecular Medicine (WIMM), University of Oxford, Oxford, United Kingdom., Oliveira MM; Department of Genetics, Federal University of Pernambuco, Recife, Brazil., Lima MM; Department of Genetics, Federal University of Pernambuco, Recife, Brazil., de Assis RA; Department of Internal Medicine, Hematology and Hemotherapy Foundation of Pernambuco, Recife, Brazil., de Melo Campos P; Hematology and Transfusion Medicine Center and., Duarte BK; Hematology and Transfusion Medicine Center and.; Department of Internal Medicine, University of Campinas, Campinas, São Paulo, Brazil; and., Bendit I; Hematology Division, LIM31, Faculdade de Medicina, University of São Paulo, São Paulo, Brazil., Rocha V; Hematology Division, LIM31, Faculdade de Medicina, University of São Paulo, São Paulo, Brazil., Rego EM; Hematology Division, LIM31, Faculdade de Medicina, University of São Paulo, São Paulo, Brazil., Traina F; Department of Internal Medicine, Medical School of Ribeirão Preto, Ribeirão Preto, Brazil., Saad ST; Hematology and Transfusion Medicine Center and.; Department of Internal Medicine, University of Campinas, Campinas, São Paulo, Brazil; and., Beltrão EI; Department of Biochemistry, Federal University of Pernambuco, Recife, Brazil., Bezerra MA; Department of Genetics, Federal University of Pernambuco, Recife, Brazil., Lucena-Araujo AR; Department of Genetics, Federal University of Pernambuco, Recife, Brazil.

Publikováno v: Blood [Blood] 2020 Mar 12; Vol. 135 (11), pp. 870-875.

Clinical impact of BAALC expression in high-risk acute promyelocytic leukemia.

Autor: Lucena-Araujo AR; Department of Genetics, Federal University of Pernambuco, Recife, Brazil.; Department of Internal Medicine, Medical School of Ribeirao Preto and.; Center for Cell Based Therapy, University of São Paulo, Ribeirao Preto, Brazil., Pereira-Martins DA; Department of Genetics, Federal University of Pernambuco, Recife, Brazil.; Department of Internal Medicine, Medical School of Ribeirao Preto and.; Center for Cell Based Therapy, University of São Paulo, Ribeirao Preto, Brazil., Koury LC; Center for Cell Based Therapy, University of São Paulo, Ribeirao Preto, Brazil., Franca-Neto PL; Department of Genetics, Federal University of Pernambuco, Recife, Brazil., Coelho-Silva JL; Department of Genetics, Federal University of Pernambuco, Recife, Brazil.; Department of Internal Medicine, Medical School of Ribeirao Preto and.; Center for Cell Based Therapy, University of São Paulo, Ribeirao Preto, Brazil., de Deus Wagatsuma VM; Department of Internal Medicine, Medical School of Ribeirao Preto and.; Center for Cell Based Therapy, University of São Paulo, Ribeirao Preto, Brazil., Melo RAM; Department of Internal Medicine, Federal University of Pernambuco, Recife, Brazil., Bittencourt R; Hematology Division, Federal University of Rio Grande do Sul, Porto Alegre, Brazil., Pagnano K; Hematology and Hemotherapy Center, University of Campinas, Campinas, Brazil., Pasquini R; Hematology Division, Federal University of Paraná, Curitiba, Brazil., Chiattone CS; Hematology Division, Santa Casa Medical School, Sao Paulo, Brazil., Fagundes EM; Hematology Division, Department of Internal Medicine, Federal University of Minas Gerais, Belo Horizonte, Brazil., Chauffaille ML; Division of Hematology, Federal University of Sao Paulo, Sao Paulo, Brazil., Schrier SL; Department of Medicine, Stanford University, Stanford, CA., Tallman MS; Leukemia Service, Memorial Sloan Kettering Cancer Center/Weill Cornell Medical College, New York, NY., Ribeiro RC; Department of Oncology, St. Jude Children's Research Hospital, Memphis, TN., Grimwade D; Department of Medical and Molecular Genetics, School of Medicine, King's College London, London, United Kingdom., Ganser A; Department of Hematology, Hemostasis, Oncology, and Stem Cell Transplantation, Hannover Medical School, Hannover, Germany., Löwenberg B; Department of Hematology, Erasmus University Medical Center, Rotterdam, The Netherlands., Lo-Coco F; Department of Biopathology, University Tor Vergata, Rome, Italy.; Santa Lucia Foundation, Rome, Italy., Sanz MA; Department of Hematology, Valencia University Medical School, Valencia, Spain.; Centro de Investigación Biomédica en Red de Cáncer, Instituto Carlos III, Madrid, Spain; and., Berliner N; Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA., Rego EM; Department of Internal Medicine, Medical School of Ribeirao Preto and.; Center for Cell Based Therapy, University of São Paulo, Ribeirao Preto, Brazil.

Publikováno v: Blood advances [Blood Adv] 2017 Sep 15; Vol. 1 (21), pp. 1807-1814. Date of Electronic Publication: 2017 Sep 15 (Print Publication: 2017).